Advertisement
Mirxes Holding Company Limited

Mirxes Holding Company Limited (2629.HK) Stock Overview

Explore Mirxes Holding Company Limited’s financial performance, market position, analyst ratings, and future outlook.

2629.HKHKSE
HealthcareBiotechnology
HK$12.41
HK$3.15(20.24%)
Hong Kong Market opens in 40h 57m
Advertisement

Mirxes Holding Company Limited (2629.HK)

Meyka AI Score

Z

Key Financials

Market Cap3.7B
P/E RatioN/A
EPS (TTM)$-2.16
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$10.30
3 Months$2.10
1 Year Target$0.00

2629.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mirxes Holding Company Limited (2629.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.84, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 3.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

65 6816 2931
2 Tukang Innovation Grove, Singapore, NaN, 618305

Company Facts

3,500 Employees
IPO DateMay 23, 2025
CountrySG

Frequently Asked Questions